Automakers are facing higher costs and increased car prices in response to President Trump’s new 25 percent tariffs on imported cars and parts. Options include moving production to the U.S., increasing domestic production, and ceasing imported model sales, but all choices will lead to price hikes for consumers. Tariffs may add thousands of dollars to car prices, prompting some companies to consider operational changes while others hope for a consumer backlash to prompt policy reversal.
Full Article
Bicycle (BCYC) Q2 Revenue Falls 69%
Bicycle Therapeutics Plc (NASDAQ:BCYC) reported Q2 2025 GAAP revenue of $2.9 million, significantly below the $9.43 million analyst estimate, while net loss per share widened to $(1.14), surpassing the $(0.95) forecast. Despite increased clinical investment and operational spending aimed at advancing its pipeline of precision-guided therapeutics using its proprietary Bicycle molecule platform, the company emphasized the need for operational discipline and clear milestones ahead. Want More Context? 🔎
Read more